"This unique platform has the potential to overcome historical ... Sanofi has signed a series of deals to expand its R&D capabilities, fuelled in part by its blockbuster immunology brand Dupixent ...

Cardio-focused company Kardigan is sewing a new digital data platform into its R&D patchwork through the acquisition of heart ...

Bayer is paying $1.5 billion upfront to claim ownership of Vividion's drug discovery platform, which uses chemoproteomics ... Vividion's in-house R&D efforts are still at the preclinical stage ...

Albert’s AI-enabled platform transforms materials science R&D and accelerates chemical innovation Albert Invent, whose end-to-end R&D platform accelerates chemical innovation in materials ...

The Company plans to showcase its R&D progress and platform innovation, including updates on multiple near- and mid-stage potentially transformative therapies that represent blockbuster ...

The new centre will focus on early-stage research and clinical development, supported by data science and AI labs.

Syneron has granted AstraZeneca access to its Synova™ platform, a high-throughput macrocyclic peptide drug R&D platform designed to advance research “exploring possible future treatments of ...

“Our independent in-house R&D began in 2009 and since then we have established our small molecule drug platform and biopharmaceutical platform,” Hui says. “Over the last four years, in ...

Shu Hai, Vice President and General Manager of the Global R&D Platform at HAIER SMARTHOME (06690.HK)(600690.SH), announced at the "Haier Smart Home 2025 Ecosystem Conference" that artificial ...

Jennifer Kyle, CEO and founder of Condor, discusses the inspiration behind creating a financial cloud platform specifically ...

as well as manufacturing innovations to improve efficiency – – Company will webcast its R&D Day event today at 9:00 a.m. E.T – “Alnylam is driving the field of RNAi therapeutics into the ...